Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

SELL
$100.78 - $112.29 $9,674 - $10,779
-96 Reduced 0.65%
14,600 $1.59 Million
Q1 2023

Apr 19, 2023

BUY
$96.86 - $114.01 $290,967 - $342,486
3,004 Added 25.69%
14,696 $1.49 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $24,810 - $29,106
-261 Reduced 2.18%
11,692 $1.28 Million
Q3 2022

Oct 12, 2022

SELL
$96.76 - $112.03 $274,991 - $318,389
-2,842 Reduced 19.21%
11,953 $1.16 Million
Q2 2022

Jul 20, 2022

SELL
$102.07 - $123.37 $664,577 - $803,262
-6,511 Reduced 30.56%
14,795 $1.61 Million
Q1 2022

Apr 28, 2022

BUY
$114.02 - $139.04 $1.07 Million - $1.31 Million
9,386 Added 78.74%
21,306 $2.52 Million
Q3 2021

Oct 12, 2021

BUY
$116.66 - $129.06 $1.39 Million - $1.54 Million
11,920 New
11,920 $1.48 Million
Q4 2020

Jan 12, 2021

SELL
$105.0 - $114.42 $1.97 Million - $2.15 Million
-18,753 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$91.64 - $111.29 $617,745 - $750,205
6,741 Added 56.12%
18,753 $2.06 Million
Q2 2020

Jul 10, 2020

SELL
$76.57 - $98.0 $91,041 - $116,522
-1,189 Reduced 9.01%
12,012 $1.11 Million
Q1 2020

Apr 21, 2020

SELL
$62.82 - $91.86 $84,430 - $123,459
-1,344 Reduced 9.24%
13,201 $984,000
Q4 2019

Jan 07, 2020

SELL
$78.51 - $87.4 $26,379 - $29,366
-336 Reduced 2.26%
14,545 $1.27 Million
Q3 2019

Oct 09, 2019

BUY
$81.84 - $88.74 $2,782 - $3,017
34 Added 0.23%
14,881 $1.25 Million
Q2 2019

Jul 08, 2019

SELL
$72.88 - $85.0 $446,900 - $521,220
-6,132 Reduced 29.23%
14,847 $1.25 Million
Q1 2019

Apr 09, 2019

BUY
$66.22 - $80.06 $66,286 - $80,140
1,001 Added 5.01%
20,979 $1.68 Million
Q4 2018

Jan 15, 2019

BUY
$65.56 - $74.27 $1.31 Million - $1.48 Million
19,978 New
19,978 $1.45 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fcf Advisors LLC Portfolio

Follow Fcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.